RetinalGenix Technologies (RetinalGenix Technologies) Total Stockholders Equity : $-1.52 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Total Stockholders Equity?

RetinalGenix Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-1.52 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. RetinalGenix Technologies's Book Value per Share for the quarter that ended in Mar. 2024 was $-0.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. RetinalGenix Technologies's Debt-to-Equity for the quarter that ended in Mar. 2024 was -0.03.

RetinalGenix Technologies Total Stockholders Equity Historical Data

The historical data trend for RetinalGenix Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Total Stockholders Equity Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

-0.08

-0.47

-1.07

-1.41

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial										-1.50	-1.78	-1.08	-1.41	-1.52

RetinalGenix Technologies (OTCPK:RTGN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

RetinalGenix Technologies's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-1.519	-	0)	/	17.8605
	=	-0.09

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

RetinalGenix Technologies's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.049	+	0)	/	-1.519
	=	-0.03

RetinalGenix Technologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.